| Literature DB >> 22368745 |
Regis Choto1, Addmore Chadambuka, Gerald Shambira, Notion Gombe, Mufuta Tshimanga, Stanley Midzi, Joseph Mberikunashe.
Abstract
INTRODUCTION: Since adoption of the measles case-based surveillance system in Zimbabwe in 1998, data has been routinely collected at all levels of the health delivery system and sent to national level with little or no documented evidence of use to identify risky populations, monitor impact of interventions and measure progress towards achieving measles elimination. We analysed this data to determine trends in the national measles case-based surveillance system (NMCBSS).Entities:
Keywords: Diseases surveillance; Measles; Zimbabwe; active surveillance; indicators
Mesh:
Year: 2012 PMID: 22368745 PMCID: PMC3283011
Source DB: PubMed Journal: Pan Afr Med J
Indicators of Quality of Measles Surveillance
| Indicators of quality of measles surveillance [ | Target |
|---|---|
| Proportion of reported suspected measles cases from whom blood specimens have been collected (excluding epidemiologically linked cases from the denominator) | ≥80% |
| Proportion of districts that have reported at least 2 suspected cases of measles with a blood specimen per year | ≥80% |
| Annualized rate of investigation (with blood specimens) of suspected measles cases | >2.0 per 100,000 population |
| Proportion of measles outbreaks investigated with blood specimens from the first five cases | ≥80% |
| Proportion of suspected measles case investigated within 3 days following notification | ≥80% |
| Proportion of serum/ dried blood specimens arriving at lab within 3 days of being taken | ≥80% |
| Proportion of laboratory confirmed measles cases | <10% |
| Proportion of feedback of serology results sent from the laboratory to the national level within 7 days of receipt of specimens at the lab | ≥80% |
| Proportion of serum specimens arriving at the national measles laboratory in good condition | >90% |
| Proportion of representative 2 serum specimens sent quarterly by the national laboratories to the regional reference labs for re-confirmation as part of quality assurance measures | >10% |
| Proportion of concordance of measles IgM results between the national measles lab and the regional reference lab | >90% |
* Main surveillance performance indicators;
** Measles laboratory performance indicators
Figure 1Number of reported suspected cases against number of cases investigated and estimated routine measles vaccine (MV) coverage per year, Jan 1999 - Dec 2000
Characteristics of Specimens Received at the Laboratory and Feedback of Results to National Level During the Period 1999 – 2008
| Year | Number of Reported Suspected Cases | Proportion of Cases Investigated % (n) | Proportion of Specimens arriving at Lab within 3 days % (n) | Proportion of specimens received at Lab in Good Condition % (n) | Proportion of Specimens with Results sent to National Level within 7 days of Receipt at Lab % (n) |
|---|---|---|---|---|---|
| 188 | 97.3 (183) | ||||
| 1222 | 83.4 (1019) | ||||
| 505 | 98.0 (495) | ||||
| 290 | 98.6 (286) | ||||
| 510 | 92.9 (474) | ||||
| 1212 | 99.9 (1211) | ||||
| 421 | 99.5 (419) | 90.7 (380) | |||
| 210 | 97.6 (205) | 87.1 (179) | |||
| 235 | 96.6 (227) | ||||
| 196 | 99.5 (195) | 82.1 (160) | 94.9 (185) |
Bold highlight indicates failure to meet recommended WHO target on respective indicators
Figure 2Average annualized rates of investigation (per 100 000 per year) by province for the period Jan 1999 - Dec 2008
Figure 3Trends of national annualised rates of investigation (per 100 000) for the period 1999 - 2008